We also realize that proper profiling and identification of those patients who are at the highest risk is important. The Mansour lab also has several patient-oriented research programs looking at predictive modeling to assess risk of fungal infection as well as the application of biomarkers to guide antimicrobial use in patients with pneumonia.
Finally, we are keen on designing novel therapeutic interventions to address life threatening infections. These investigations provide the foundation for the development of cellular therapies for infectious diseases as well as improved vaccine strategies.